Nintedanib bei progressiver Nicht-IPF-Lungenfibrose – eine SubgruppenanalyseNintedanib in progressive non-IPF pulmonary fibrosis—A subgroup analysis

被引：0
|
作者：
Philipp Markart
机构：
[1] Universitätsmedizin Marburg,Medizinische Klinik V (Pneumologie), Herzthoraxzentrum, Klinikum Fulda gAG
[2] Campus Fulda,Medizinische Klinik und Poliklinik II
[3] Universitätsklinikum Gießen und Marburg GmbH,undefined
[4] Standort Gießen,undefined
来源：
Der Pneumologe | 2020年 / 17卷 / 5期
关键词：
D O I：
10.1007/s10405-020-00341-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：350 / 351
页数：1
相关论文
共 41 条
  • [21] Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)
    Guenther, Andreas
    Prasse, Antje
    Kreuter, Michael
    Neuser, Petra
    Rabe, Klaus
    Bonella, Francesco
    Bonnet, Reiner
    Grohe, Christian
    Held, Matthias
    Wilkens, Heinrike
    Hammerl, Peter
    Koschel, Dirk
    Blaas, Stefan
    Wirtz, Hubert
    Ficker, Joachim
    Neumeister, Wolfgang
    Schoenfeld, Nicolaus
    Claussen, Martin
    Kneidinger, Nikolaus
    Frankenberger, Marion
    Hummler, Simone
    Kahn, Nicolas
    Tello, Silke
    Freise, Julia
    Welte, Tobias
    Schade-Brittinger, Carmen
    Behr, Juergen
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [22] POOLED ANALYSIS OF MORTALITY DATA FROM THE TOMORROW AND INPULSIS TRIALS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Corte, T.
    Richeldi, L.
    Kirsten, A.
    Roman, J.
    Le Maulf, F.
    Hallmann, C.
    Stowasser, S.
    Lasky, J.
    RESPIROLOGY, 2015, 20 : 87 - 87
  • [23] Efficacy and Safety of Nintedanib in US and Non-US Patients With Idiopathic Pulmonary Fibrosis (IPF) in the INPULSIS Trials
    Huggins, John
    Kaye, Mitchell
    Bailes, Zelie
    Esser, Dirk
    Conoscenti, Craig
    Flaherty, Kevin
    CHEST, 2015, 148 (04)
  • [24] Long-term Safety Data of Inhaled Pirfenidone (AP01) in Idiopathic Pulmonary Fibrosis (IPF) and Non-IPF Interstitial Lung Disease (ILD) Patients
    Woodhead, F. A.
    Nair, D.
    Bao, H.
    Freeman, L.
    Otto, K.
    Surber, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [25] IN NON-IPF FIBROSING ILD, E-LUNG BIOMARKERS ARE ASSOCIATED WITH THE FUTURE DEVELOPMENT OF PROGRESSIVE PULMONARY FIBROSIS INDEPENDENT OF UIP STATUS ON CT SCAN
    George, Peter
    Rennison-Jones, Christian
    Ottink, Finja
    Baggs, Rachel
    Sifostratoudaki, Aliki
    Fernandez, Claire
    Gerry, Stephen
    Harston, George
    Devaraj, Anand
    CHEST, 2024, 166 (04) : 3264A - 3265A
  • [26] Nebulised pirfenidone in non-idiopathic pulmonary fibrosis (IPF) progressive pulmonary fibrosis (PPF): first look at FVC data
    West, Alex
    Lawrence, Alexandra
    Bao, Hao
    Nair, Deepthi
    Thompson, Courtney
    Woodhead, Felix
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [27] COST-EFFECTIVENESS ANALYSIS OF PIRFENIDONE TABLETS COMPARED WITH NINTEDANIB FOR IDIOPATHIC PULMONARY FIBROSIS (IPF) TREATMENT IN TURKEY
    Erdogan-Ciftci, E.
    Yanik, L.
    Ersoy, Akyol B.
    Safak, K.
    Thuresson, P. O.
    VALUE IN HEALTH, 2019, 22 : S851 - S851
  • [28] Effect Of Patient Demographic And Functional Characteristics On Long-Term Efficacy Of Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Subgroup Analysis From Inpulsis-On
    Kreuter, M.
    Song, J.
    Huggins, J. T.
    Quaresma, M.
    Stansen, W.
    Stowasser, S.
    Crestani, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [29] Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry
    Tsubouchi, Kazuya
    Hamada, Naoki
    Tokunaga, Shoji
    Ichiki, Katsuyuki
    Takata, Shohei
    Ishii, Hiroshi
    Kitasato, Yasuhiko
    Okamoto, Masaki
    Kawakami, Satoru
    Yatera, Kazuhiro
    Kawasaki, Masayuki
    Fujita, Masaki
    Yoshida, Makoto
    Maeyama, Takashige
    Harada, Taishi
    Wataya, Hiroshi
    Torii, Ryo
    Komori, Masashi
    Mizuta, Yuichi
    Tobino, Kazunori
    Harada, Eiji
    Yabuuchi, Hidetake
    Nakanishi, Yoichi
    Okamoto, Isamu
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [30] PTEN Expression in Progressive (Idiopathic Pulmonary Fibrosis - IPF) Versus Non-Progressive (Sub-Pleural Fibrosis in Recurrent Spontaneous Pneumothorax - RSP) Pulmonary Fibrosis
    Nudelman, R. J.
    Schutte, S.
    Lan, R.
    Leslie, K. O.
    Jagirdar, J.
    MODERN PATHOLOGY, 2012, 25 : 485A - 485A
12345